Trice Brown, The Auburn Plainsman; Nobel laureate takes stance against allowing research to be intellectual property
"George Smith, recipient of a 2018 Nobel Prize for Chemistry, spoke to
a crowd of students and faculty about the problems that arise from
making publicly funded research intellectual property.
Smith said one of the greatest problems facing the scientific
research community is the ability of universities to claim intellectual
property rights on publicly funded research.
“I think that all research ought not to have intellectual — not to be
intellectual property,” Smith said. “It’s the property of everyone.”"
Issues and developments related to IP, AI, and OM, examined in the IP and tech ethics graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology", coming in Summer 2025, includes major chapters on IP, AI, OM, and other emerging technologies (IoT, drones, robots, autonomous vehicles, VR/AR). Kip Currier, PhD, JD
Showing posts with label Humira. Show all posts
Showing posts with label Humira. Show all posts
Thursday, April 11, 2019
Monday, May 22, 2017
The World’s Best-Selling Drug Just Lost a Key Patent Battle; Fortune, May 18, 2017
Sy Mukherjee, Fortune;
The World’s Best-Selling Drug Just Lost a Key Patent Battle
"The rheumatoid arthritis and psoriasis medicine has recently been a target of biopharma companies that are trying to make generic Humira copycats called "biosimilars."...
Once the drug does fall off the patent cliff, however, AbbVie could be in for some rough times. Humira sales make up more than 60% of its revenues."
Subscribe to:
Posts (Atom)